Learn more

PHARMA ZENTRALE GMBH

Overview
  • Total Patents
    112
About

PHARMA ZENTRALE GMBH has a total of 112 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and macromolecular chemistry and polymers are CENTELION S A S, CENTELION and AVESTHA GENGRAINE TECH PVT LTD.

Patent filings per year

Chart showing PHARMA ZENTRALE GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Proppert Hans 88
#2 Sonnenborn Ulrich 77
#3 Malinka Juergen 41
#4 Schulze Juergen 40
#5 Hacker Joerg 37
#6 Blum-Oehler Gabriele 23
#7 Schulze Jurgen 22
#8 Malinka Jurgen 22
#9 Rietschel Ernst Theodor 20
#10 Blum-Oehler Gabrielle 20

Latest patents

Publication Filing date Title
EP2628793A1 Recombinant escherichia coli strains
DE10328669A1 Plasmid-free clone of E. coli strain DSM 6601
DE10234570A1 New DNA fragment encoding mutant O6-antigen polymerase, useful for identifying Escherichia coli DSM 6601 and for attenuating other O6 serotype strains
DE10209958A1 Escherichia coli DSM 6601 as antiphlogistic agent, useful for treating inflammatory skin diseases and rheumatic disease
DE10126284A1 Using specific Escherichia coli strains to treat or prevent infection by enteroinvasive bacteria or related microorganisms
DE10055789A1 DNA sequence and microcin from Escherichia coli strain DSM 6601
DE10013539A1 Escherichia coli lipopolysaccharides, process for their preparation and their uses
DE19915772A1 Procedure for the identification of Escherichia coli strain DSM 6601
CZ20001874A3 DNA sequence
CZ20001873A3 Method for identifying Escherichia coli DSM 6601 and sequences used during identification
DE19844191A1 New Escherichia coli lipopolysaccharide useful as an immunostimulant for microbiological, biotechnology, analytical, diagnostic and/or medical purposes
DE19751907A1 Use of Escherichia coli strain DSM 6601 for the treatment of diarrhea in the veterinary sector
DE19751242A1 DNA sequences from Fimbrien genes from Escherichia coli strain DSM 6601
DE19713543A1 Bacterial plasmids